Company intelligence / Profile preview

mPedigree

Ownership: Private
Development stage: Commercial

Overview

mPedigree has deployed its product authentication and anti-counterfeiting solutions across Africa and Asia, partnering with pharmaceutical companies, regulators, telecom operators, and Fortune 500 firms. Its Goldkeys platform has been used to authenticate over 500 million drug packets for clients such as AstraZeneca, Roche, and Sanofi. Empirical analysis in Nigeria showed a 65% reduction in counterfeit circulation for brands using the system. The company’s technology has been adopted as part of national anti-counterfeit initiatives in countries like Nigeria and Kenya.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Hewlett Packard (HP)Zain TelecommunicationsNational regulatory agencies such as NAFDAC (Nigeria), KEPHIS (Kenya)Pharmaceutical companies including AstraZeneca, Roche, Sanofi

Beyond the preview

Go deeper on mPedigree.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on mPedigree.

Explore the full profile